Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE)

CUSIP: Y95308105

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Ordinary Shares, no par value
Shares outstanding
182,917,028
Total 13F shares
128,616,529
Share change
+5,965,108
Total reported value
$1,591,015,441
Put/Call ratio
77%
Price per share
$12.37
Number of holders
181
Value change
+$86,595,360
Number of buys
113
Number of sells
62

Quarterly Holders Quick Answers

What is CUSIP Y95308105?
CUSIP Y95308105 identifies WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE) as of Q4 2024

As of 31 Dec 2024, Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE) was held by 181 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 128,616,529 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock, Inc., MAVERICK CAPITAL LTD, Driehaus Capital Management LLC, M28 Capital Management LP, PRICE T ROWE ASSOCIATES INC /MD/, Kynam Capital Management, LP, Bellevue Group AG, and 683 Capital Management, LLC. This page lists 181 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.